The membrane attack complex of complement causes severe demyelination associated with acute axonal injury

Journal of Immunology

Volumn 168, Issue 1, 2002, Pages 458-465

  Mead, R J ^a   Singhrao, S K ^a   Neal, J W ^a   Lassmann, H ^a   Morgan, B P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CELL INFILTRATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; IMMUNOPATHOGENESIS; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; RAT;

EID: 0036135588     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.1.458     Document Type: Article

References (46)

1. Pathogenesis of multiple sclerosis
2. Pathology and pathogenesis of demyelinating diseases
3. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis
4. Multiple sclerosis as a neuronal disease
5. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss
6. Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis
7. Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex
8. The application of tissue culture to the study of experimental allergic encephalomyelitis. II. Serum factors responsible for demyelination
9. The role of complement in the pathogenesis of experimental allergic encephalomyelitis
10. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
11. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
12. Soluble recombinant complement receptor I inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis
13. Attenuation of experimental autoimmune demyelination in complement-deficient mice
14. C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptideinduced experimental autoimmune encephalomyelitis in mice
15. Immunocytochemical localization of the terminal complement complex in multiple sclerosis
16. Multiple sclerosis: In situ evidence for antibody and complement-mediated demyelination
17. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
18. Identification of autoantibodies associated with myelin damage in multiple sclerosis
19. Hereditary C6 deficiency in a strain of PVG/c rats
20. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome
21. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3
22. Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals
23. Role of complement in the aetiology of Pick's disease?
24. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis
25. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis
26. The role of B cells and autoantibodies in multiple sclerosis
27. The role of complement in disorders of the nervous system
28. The susceptibility of rat strains to experimental allergic encephalomyelitis
29. Experimental autoimmune encephalomyelitis in genetically resistant rats: PVG rats resist active induction of EAE but are susceptible to and can generate EAE effector T cell lines
30. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis. PVG/c and BN rats: Implication for susceptibility to autoimmune encephalomyelitis
31. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts
32. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat
33. Active Heymann nephritis in complement component C6 deficient rats
34. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis
35. Phagocytosis of myelin in demyelinative disease: A review
36. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor α and nitric oxide
37. Studies on demyelination in vitro: Requirements of the membrane attack components of the complement system
38. Axonal damage in multiple sclerosis lesions
39. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative study of axonal injury in active, inactive and remyelinated lesions
40. Axonal pathology in myelin disorders
41. Axonal pathology in multiple sclerosis: A historical note
42. Conduction in segmentally demyelinated mammalian central axons
43. Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis
44. Differential expression of individual complement regulators in the brain and choroid plexus
45. Therapeutic intervention in acute and chronic disease with anti-C5 therapy